Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features


DURCAN E., Keskin F. E., ÖZKAYA H. M., ŞİROLU S., Sahin S., Korkmaz O. P., ...More

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.130, no.2, pp.125-133, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 130 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.1055/a-1523-7216
  • Journal Name: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.125-133
  • Keywords: FGFR-4, Ki-67, pituitary adenomas, tumor aggressiveness
  • Istanbul University Affiliated: Yes

Abstract

Purpose To investigate the relationship of Fibroblast Growth Factor Receptor-4 (FGFR-4) expression with radiologic, pathologic, and clinical parameters in pituitary adenomas.